Literature DB >> 5075512

Gangliosides of human, bovine, and rabbit plasma.

R K Yu, R W Ledeen.   

Abstract

Gangliosides were isolated from human, bovine, and rabbit plasma and were quantified by gas-liquid chromatography. Purification was achieved by sequential use of partitioning in solvents, DEAE-Sephadex chromatography, base treatment, and silicic acid chromatography. Human and bovine plasma yielded slightly more than 1 micro mole of lipid-bound sialic acid/100 ml; for rabbit plasma the value was 0.28 micro mole/100 ml. The total bovine plasma ganglioside fraction contained equal amounts of N-acetylneuraminic and N-glycolylneuraminic acids, rabbit plasma gangliosides had about 1% of the latter, and the human plasma sample contained only the former. Thin-layer chromatography revealed important differences among the plasmas from the three species, but all possessed hematosides and hexosamine-containing gangliosides. The approximate ratios of these two categories, based on sialic acid content, were (hematosides: hexosamine-type): human, 2:1; rabbit, 3:2; and bovine, 2:3. The fatty acid compositions of both categories were characteristic of extraneural gangliosides and included six major acids: palmitic, stearic, behenic, tricosanoic, lignoceric, and nervonic. The major long-chain base in each sample was sphingosine, while only a trace of the C(20) isomer was detected.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 5075512

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  65 in total

Review 1.  Lipid changes in Niemann-Pick disease type C brain: personal experience and review of the literature.

Authors:  M T Vanier
Journal:  Neurochem Res       Date:  1999-04       Impact factor: 3.996

2.  Glycosyltransferase activities in cultured endothelial cells of bovine brain microvascular origin.

Authors:  T Kanda; T Ariga; M Yamawaki; H Yoshino; X B Gu; R K Yu
Journal:  Neurochem Res       Date:  1997-04       Impact factor: 3.996

3.  Long-chain neutral glycolipids and gangliosides of murine fibroblast lines and their low- and high-tumourigenic hybrids.

Authors:  K Itaya; S I Hakomori; G Klein
Journal:  Proc Natl Acad Sci U S A       Date:  1976-05       Impact factor: 11.205

4.  Synthesis, Processing, and Function of N-glycans in N-glycoproteins.

Authors:  Erhard Bieberich
Journal:  Adv Neurobiol       Date:  2014

5.  Cholera toxin interactions with thyrotropin receptors on thyroid plasma membranes.

Authors:  B R Mullin; S M Aloj; P H Fishman; G Lee; L D Kohn; R O Brady
Journal:  Proc Natl Acad Sci U S A       Date:  1976-05       Impact factor: 11.205

6.  Regulation of the oncodevelopmental expression of type 1 chain ABH and Lewis(b) blood group antigens in human colon by alpha-2-L-fucosylation.

Authors:  T F Orntoft; P Greenwell; H Clausen; W M Watkins
Journal:  Gut       Date:  1991-03       Impact factor: 23.059

7.  Glycosphingolipid antigens of Leishmania (Leishmania) amazonensis amastigotes identified by use of a monoclonal antibody.

Authors:  C L Barbiéri; S Giorgio; A J Merjan; E N Figueiredo
Journal:  Infect Immun       Date:  1993-05       Impact factor: 3.441

8.  Possible role of ceramide in defining structure and function of membrane glycolipids.

Authors:  R Kannagi; E Nudelman; S Hakomori
Journal:  Proc Natl Acad Sci U S A       Date:  1982-06       Impact factor: 11.205

9.  A monoclonal antibody with binding and inhibiting activity towards human pancreatic carcinoma cells. I. Immunohistological and immunochemical characterization of a murine monoclonal antibody selecting for well differentiated adenocarcinomas of the pancreas.

Authors:  K Bosslet; H F Kern; E J Kanzy; A Steinstraesser; A Schwarz; G Lüben; H U Schorlemmer; H H Sedlacek
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

10.  Effect of anti-glycosphingolipid monoclonal antibodies in pathogenic fungal growth and differentiation. Characterization of monoclonal antibody MEST-3 directed to Manpalpha1-->3Manpalpha1-->2IPC.

Authors:  Marcos S Toledo; Loriane Tagliari; Erika Suzuki; Claudinei M Silva; Anita H Straus; Helio K Takahashi
Journal:  BMC Microbiol       Date:  2010-02-15       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.